Celiac Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Celiac Disease Clinical Trials Market Report Overview
The Celiac Disease clinical trial market research report provides an overview of the Celiac Disease Clinical trials scenario. This report provides top-line data relating to the clinical trials on Celiac Disease and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · Europe
· North America · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· Australia · Italy · Finland · Canada · The Netherlands · India · Sweden · The UK · New Zealand |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Takeda Pharmaceutical Co Ltd
· ImmusanT Inc · 9 Meters Biopharma Inc · Alvine Pharmaceuticals, Inc. (Inactive) · Alba Therapeutics Corp · Amgen Inc · Dr. Falk Pharma GmbH · F. Hoffmann-La Roche Ltd · Cour Pharmaceuticals Development Co Inc · Crescent Capital Partners |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Celiac Disease Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Celiac Disease clinical trials market are Europe, North America, Asia-Pacific, the Middle East & Africa, and South & Central America, among others. Europe dominates the market with more than 35% of the clinical trials conducted as of July 2023.
In a country-wise analysis, as of July 2023, the US has the highest number of Celiac Disease clinical trials, followed by Australia, Italy, Finland, Canada, the Netherlands, India, Sweden, the UK, and New Zealand.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy has the highest proportion of Celiac Disease to Gastrointestinal clinical trials as of July 2023. Moreover, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of Celiac Disease to Gastrointestinal clinical trials as of July 2023.
Celiac Disease Clinical Trials Analysis by Regions, 2023 (%)
Buy Full Report for More Regional Insights into Celiac Disease Clinical Trials Market
Celiac Disease Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Celiac Disease clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
Celiac Disease Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Celiac Disease Clinical Trials Market
Celiac Disease Clinical Trials Market - Competitive Landscape
The leading sponsors in the Celiac Disease clinical trials market are Takeda Pharmaceutical Co Ltd, ImmusanT Inc, 9 Meters Biopharma Inc, Alvine Pharmaceuticals, Inc. (Inactive), Alba Therapeutics Corp, Amgen Inc, Dr. Falk Pharma GmbH, F. Hoffmann-La Roche Ltd, Cour Pharmaceuticals Development Co Inc, and Crescent Capital Partners. Takeda Pharmaceutical Co Ltd led the Celiac Disease clinical trials market in July 2023.
Celiac Disease Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Sponsors in Celiac Disease Clinical Trials Market
Segments Covered in the Report
Celiac Disease Clinical Trials Regional Outlook (2023)
- Europe
- North America
- Asia-Pacific
- Middle East & Africa
- South & Central America
Celiac Disease Clinical Trials Country Outlook (2023)
- The US
- Australia
- Italy
- Finland
- Canada
- The Netherlands
- India
- Sweden
- The UK
- New Zealand
Celiac Disease Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
- The report reviews the top companies involved and enlists all trials pertaining to the company
- The report provides all the unaccomplished trials with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
ImmusanT Inc
9 Meters Biopharma Inc
Alvine Pharmaceuticals, Inc. (Inactive)
Alba Therapeutics Corp
Amgen Inc
Dr. Falk Pharma GmbH
F. Hoffmann-La Roche Ltd
Cour Pharmaceuticals Development Co Inc
Crescent Capital Partners
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading region in the Celiac Disease clinical trials market?
Europe is the leading region in the Celiac Disease clinical trials market as of July 2023.
-
Which is the leading country in the Celiac Disease clinical trials market?
The US is the leading country in the Celiac Disease clinical trials market as of July 2023.
-
Which is the leading sponsor type in the Celiac Disease clinical trials market?
Institution is the leading sponsor type in the Celiac Disease clinical trials market as of July 2023.
-
Who are the leading sponsors in the Celiac Disease clinical trials market?
The leading sponsors in the Celiac Disease clinical trials market are Takeda Pharmaceutical Co Ltd, ImmusanT Inc, 9 Meters Biopharma Inc, Alvine Pharmaceuticals, Inc. (Inactive), Alba Therapeutics Corp, Amgen Inc, Dr. Falk Pharma GmbH, F. Hoffmann-La Roche Ltd, Cour Pharmaceuticals Development Co Inc, and Crescent Capital Partners.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.